top of page
Search Results

124 items found for "fibrotic bone disease"

  • Ep 78 with Dr. Stuart Maudsley

    the Receptor Biology Lab, focuses on the development of novel GPCR-based therapeutics that interdict diseases basis of a new technology-based start-up company, HeptOME , to help screen and develop novel longevity/disease-regulating compounds with multidimensional disease efficacy profiles.

  • Ep 79 with Dr. Graeme Milligan

    the co-founder of both Caldan Therapeutics (2015) which discovers novel therapeutics for metabolic diseases Type 2 Diabetes and other indications including non-alcoholic steatohepatitis (NASH) and inflammatory diseases

  • Ovarian cancer G protein-coupled receptor 1 (OGR1) deficiency exacerbates crystal deposition and kidney injury in oxalate nephropathy in female mice

    While GPR4 deficiency did not show major alterations in disease progression, OGR1 KO mice had higher setting of oxalate-induced nephropathy, the lack of the proton-activated GPCR GPR4 does not influence disease Wagner , Pedro Henrique Imenez Silva Tags G-protein-coupled receptors , acid-base , chronic kidney disease

  • Newsletter Sign Up | Dr. GPCR Ecosystem

    curated the major advances in understanding GPCR biology and moving closer to targeting receptors in diseases

  • Ep 80 with Dr. Andrew Tobin

    research laboratory of around 15 staff supported by basic research grants investigating aspects of disease biology and the action of drugs in the context of disease.

  • Ep 142 with Dr Claudia Stäubert

    of studying metabolites and their receptors, the relationship between metabolites, gut health, and disease They briefly touched upon the link between GPCRs and diseases, such as diabetes, but did not delve into Metabolites, Gut Health, and Disease Progression Yamina and Claudia had a discussion about the relationship between metabolites, gut health, and disease progression. Both agreed on the complexity of the topic, with Claudia concluding that diseases might first affect

  • Ep 90 with Dr. Nariman Balenga

    parathyroid glands of patients with hyperparathyroidism and their impact on body calcium homeostasis and bone

  • Ep 46 with Dr Gunnar Schulte

    and pharmacology aiming to understand the role of WNT/Frizzled signaling in biology, physiology, and disease find, create and optimize Frizzled-targeting small molecule drugs to improve future therapies of human disease

  • Ep 152 with Dr Arthur Christopoulos

    , molecular and cellular pharmacology, medicinal chemistry, and preclinical models of behaviour and disease work has been applied to studies encompassing neurological and psychiatric disorders, cardiovascular disease They highlighted the importance of fine-tuning the approach to suit different diseases and interdisciplinary The discussion also emphasized the need for a disease-specific approach, considering the clinical context Arthur and Yamina discussed the potential of autoantibodies and allosteric modulation in the context of disease

  • Ep 65 with Dr. Sudarshan Rajagopal

    His clinical focus is on pulmonary arterial hypertension, a disease of the pulmonary arterioles that causes right heart failure, and he serves as co-director of the Duke Pulmonary Vascular Disease Center

  • Ep 70 with Dr. Stephen Ferguson

    the investigation of the regulation of G protein-coupled receptors signaling mechanisms in health and disease investigating the role of metabotropic glutamate receptor signaling in Huntington’s and Alzheimer’s disease

  • Ep 143 with Dr Davide Calebiro

    and obtained a PhD in Molecular Medicine and a Clinical Specialisation in Endocrinology and Metabolic Disease protein-coupled receptor (GPCR) signalling and their alterations in endocrine, metabolic and cardiovascular diseases

  • Ep 103 with Dr Kathleen Caron

    laboratory has gained valuable insights into the genetic basis and pathophysiology of lymphatic vascular disease , preeclampsia and sex-dependent cardiovascular disease.

  • Session VIII | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    during prolonged cold exposure Anastasia Georgiadi ADGRF5-mediated regulation of cardiac health and disease Netherlands; 2Department of Experimental Immunology, Amsterdam institute for Immunology and Infectious diseases Institute of Innate Immunity, University Hospital Bonn, University of Bonn, 3. Georgiadi on the web Endocrine Pharmacology Google Scholar ADGRF5-mediated regulation of cardiac health and disease

  • Ep 53 with Dr. Timo De Groof

    gained experience in the identification and characterization of llama-derived antibodies in inflammatory diseases conformations, while also focusing on their therapeutic potential in oncology and transplant infectious disease

  • G protein-coupled receptors related to autoimmunity in postural orthostatic tachycardia syndrome

    In particular, the association of the disease with several types of anti-G protein-coupled receptor ( To date, POTS is recognized as one of the sequelae of coronavirus disease 2019 (COVID-19) and its frequency

  • Ep 69 with Dr. Stephen Ferguson

    the investigation of the regulation of G protein-coupled receptors signaling mechanisms in health and disease investigating the role of metabotropic glutamate receptor signaling in Huntington’s and Alzheimer’s disease

  • Enterococcus-derived tyramine hijacks α2A-adrenergic receptor in intestinal stem cells to exacerbate colitis

    intestinal stem cells to exacerbate colitis Published date May 21, 2024 Abstract "Inflammatory bowel disease Wang , Xinyang Song , Shu Zhu , Wen Pan Tags Enterococcus , IBD , ISCs , colitis , inflammatory bowel disease

  • "Have a nice weekend, and I'll see you tomorrow!": RAMP-interacting GPCR Pathways

    laboratory has gained valuable insights into the genetic basis and pathophysiology of lymphatic vascular disease , preeclampsia and sex-dependent cardiovascular disease.

  • GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis

    However, the underlying mechanism of virus-cancer immunological interaction during disease pathogenesis comprehensive proteogenomic characterization of natural killer/T-cell lymphoma (NKTCL), a representative disease

  • Regulator of G protein signaling 16 restrains apoptosis in colorectal cancer through disrupting TRAF6-TAB2-TAK1-JNK/p38 MAPK signaling

    elevated RGS16 protein level in CRC, and found that patients with RGS16-high tumors exhibited decreased disease-specific survival (DSS) and disease-free survival (DFS) compared to those with low RGS16 expression.

  • Evolutionary diversity of CXCL16-CXCR6: Convergent substitutions and recurrent gene loss in sauropsids

    This axis is linked to diseases like HIV/SIV, cancer, and COVID-19. CXCR6 in chickens may have altered CD8 TRM cell abundance, with implications for immunity against viral diseases

  • TIPE proteins control directed migration of human T cells by directing GPCR and lipid second messenger signaling

    directed migration (also referred to as chemotaxis) is a common pathogenic mechanism of inflammatory diseases have implications for therapeutically targeting TIPE proteins in human inflammatory and autoimmune diseases

  • Ep 05 with Dr. Terry Hébert

    Much of his work is based on GPCR signaling in the context to cardiovascular diseases.

  • GPCR Retreat Schedule 2023

    More Friday, November 3rd / 9:20 AM Cannabinoid compounds to augment L-DOPA treatment in Parkinson's Disease and Genetic Preclinical Models of Ghrelin Receptor Functional Selectivity to Investigate Metabolic Disease Friday, November 3rd / 11:05 AM Biased agonism at the GLP-1 receptor: from structure to animal models of disease Columbia Read More Friday, November 3rd / 2:10 PM Genetic Deletion of Atypical VGLUT3 Rescues Huntington’s Disease

  • Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem

    the identification of drugs targeting the unique aGPCR receptor family and customize the method for disease-relevant recruited by Vertex Pharmaceuticals (Canada) where he worked on biomarker discovery for inflammatory bowel disease and small molecules drug discovery for polycystic kidney disease. novel pharmacological targets and contribute to the development of innovative treatments for a range of diseases

  • Dr. GPCR Summit 2021 Live Talks

    September 14, 2021 at 2:00:00 PM Learn More >> GPCRomics: Identifying novel GPCR targets in health and disease human GPCR to create self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease More >> Phosphorylation of the M1 muscarinic acetylcholine receptor protects from neurodegenerative disease

  • GPCR Retreat 2023 - Part II

    in a sex-selective manner and how this can influence drug discovery in the area of neurodegenerative diseases She is currently working to understand the signaling and degradation of GPCRs in disease states to help

bottom of page